• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Tumor Cell Lines

OSCA-8

  • BSL
  • 38
OSCA-8 is a canine osteosarcoma cell line derived from a left-shoulder tumor of a 1-year old intact male Rottweiler.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options

OSCA-8, an osteosarcoma cell line, originates from a left-shoulder tumor in a 1-year-old male Rottweiler. It thrives in vitro and gives rise to both orthotopic and heterotopic tumor xenografts in immunodeficient mice. Its gene expression profile aligns with the most aggressive molecular phenotype of osteosarcoma. This type of cancer emerges from primitive transformed cells of mesenchymal origin, demonstrating osteoblastic differentiation and generating malignant osteoid.

 

Why choose OSCA-8 from AcceGen?

OSCA-8 from AcceGen is preferred as a high-quality and highly viable cell product. AcceGen ensures professional handling with optimal incubation conditions. The cells are rigorously tested through STR profiling to eliminate mycoplasma contamination and any presence of mouse, rat, Chinese hamster, or African green monkey contaminants. Additionally, OSCA-8 is authenticated using a canine STR marker, enhancing its credibility and practicality.

Product Code

OSCA-8; OSCA8; OSA8

Species

Canine

Cat.No

ABC-TC5571

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Shipping Info

Dry ice

Growth Conditions

37 ℃, 5% CO2

Storage

Liquid Nitrogen

Product Type

Canine Sarcoma Cell Lines

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

View More
View Product Image

Application

  • FOR RESEARCH USE ONLY

  • The OSCA-8 cell line’s relevance lies in its application to address the challenges of canine osteosarcoma, characterized by high metastasis rates and a grim prognosis. It serves as a valuable tool to examine inhibitor cytotoxicity, elucidate resistance mechanisms against established drugs, and innovate novel therapeutic approaches to induce apoptosis. OSCA-8 contributes significantly to advancing the understanding and management of this aggressive disease in canines.

Inquiring OSCA-8

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

  • Canine (22)
  • Left Shoulder (1)
  • Sarcoma (40)
AcceGen Scroll Top Button